Altered ioflupane single‐photon emission computed tomography in anti‐IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature
European Journal of Neurology2020Vol. 28(4), pp. 1392–1395
Citations Over TimeTop 14% of 2020 papers
Carmen González‐Ávila, Laura Casado‐Fernández, Inés Muro, Javier Villacieros‐Álvarez, José Vivancos, Sonia Quintas
Abstract
Ioflupane SPECT abnormalities, though scarcely described, are not uncommon in anti-IgLON5 disease. They could be related to nigrostriatal dopaminergic degeneration in the context of the tauopathy component of the disease, but further case descriptions are necessary.
Related Papers
- → Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies(2019)69 cited
- → Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis(2017)7 cited
- → An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap(2000)8 cited
- → Disturbance of cerebral copper trafficking in tauopathy: A pilot study in a mouse model of tauopathy using 64CUCL2 PET/CT(2023)
- → Role of Aging and Amyloid in Viral Vector Mediated Tauopathy(2023)